Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)
US9771431B2 · kind B2 · utility
2Cited by
47References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2012 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Feb 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.